- Home
- VKI vs SRDX Comparison
VKI vs SRDX Comparison
Compare VKI & SRDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VKI
- SRDX
- Stock Information
- Founded
- VKI 1993
- SRDX 1979
- Country
- VKI United States
- SRDX United States
- Employees
- VKI N/A
- SRDX N/A
- Industry
- VKI Finance Companies
- SRDX Medical/Dental Instruments
- Sector
- VKI Finance
- SRDX Health Care
- Exchange
- VKI Nasdaq
- SRDX Nasdaq
- Market Cap
- VKI 369.0M
- SRDX 415.4M
- IPO Year
- VKI N/A
- SRDX 1998
- Fundamental
- Price
- VKI $8.70
- SRDX $31.94
- Analyst Decision
- VKI
- SRDX Buy
- Analyst Count
- VKI 0
- SRDX 3
- Target Price
- VKI N/A
- SRDX $43.00
- AVG Volume (30 Days)
- VKI 112.8K
- SRDX 290.5K
- Earning Date
- VKI 01-01-0001
- SRDX 11-05-2025
- Dividend Yield
- VKI 4.52%
- SRDX N/A
- EPS Growth
- VKI N/A
- SRDX N/A
- EPS
- VKI N/A
- SRDX N/A
- Revenue
- VKI N/A
- SRDX $120,801,000.00
- Revenue This Year
- VKI N/A
- SRDX N/A
- Revenue Next Year
- VKI N/A
- SRDX $3.38
- P/E Ratio
- VKI N/A
- SRDX N/A
- Revenue Growth
- VKI N/A
- SRDX N/A
- 52 Week Low
- VKI $7.07
- SRDX $26.00
- 52 Week High
- VKI $8.98
- SRDX $40.39
- Technical
- Relative Strength Index (RSI)
- VKI 82.77
- SRDX 35.15
- Support Level
- VKI $8.25
- SRDX $31.34
- Resistance Level
- VKI $8.68
- SRDX $33.17
- Average True Range (ATR)
- VKI 0.07
- SRDX 1.01
- MACD
- VKI 0.04
- SRDX -0.41
- Stochastic Oscillator
- VKI 96.61
- SRDX 10.33
About VKI Invesco Advantage Municipal Income Trust II of Beneficial Interest (DE)
Invesco Advantage Municipal Income Trust II is a diversified, closed-end management investment company. The investment objective of the company is to provide common shareholders with a high level of current income exempt from federal income tax, consistent with preservation of capital.
About SRDX Surmodics Inc.
Surmodics Inc is a provider of performance coating technologies for intravascular medical devices and chemical and biological components for in vitro diagnostic (IVD) immunoassay tests and microarrays. The company's reportable segments are; Medical Device and In Vitro Diagnostics. Maximum revenue for the company is derived from its Medical Device segment which is involved in the manufacturing and licensing of performance coatings, including surface modification coating technologies and drug-delivery coating technologies. This segment also manufactures vascular intervention medical devices, including drug-coated balloons, mechanical thrombectomy devices, and radial access balloon catheters and guide sheaths. Geographically, the company derives key revenue from its domestic market.